Literature DB >> 8338191

Familial tumoral calcinosis. A clinical, histopathologic, and ultrastructural study with an analysis of its calcifying process and pathogenesis.

R E Slavin1, J Wen, D Kumar, E B Evans.   

Abstract

We describe histopathologic and ultrastructural changes in tumoral calcinosis (TC) occurring in seven siblings from a single family. Tumoral calcinosis appears to be triggered by bleeding followed by aggregation of foamy histiocytes. These in turn are transformed, with participation of collagenolysis, into cystic cavities lined by osteoclast-like giant cells and histiocytes--the lesion resembling adventitious bursae. Movement and friction, forces generated from the periarticular location of the TC lesions, putatively are key to this transformation. Concomitantly, two calcifying events develop, possibly driven by concurrent hyperphosphatemia or endogenous hypervitaminosis D. One occurs on membranous fragments in antiprotease-containing large cytoplasmic vesicles within osteoclast-like giant cells and mononuclear cells lining the TC cavities; the second, in the TC locules on membranous and cellular debris derived from cavity-lining cells and erythrocytes. The TC cavities ultimately fill with calcified material, losing their synovial-like lining, become encapsulated by fibrous tissue, and ossify. Hydroxyapatite may gain entrance to capillary lumens and embolize to the lung. We conclude that TC represents a disordered reparative process that often is exaggerated because episodes of bleeding, caused by TC-induced vascular injury, provoke development of new lesions. The capricious response of TC to treatment is correlated with its morphologic features.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8338191

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  27 in total

1.  Phosphoglyceride crystal deposition disease presenting as multiple paragastric masses.

Authors:  Shinichi Yachida; Noriyoshi Fukushima; Yukihiro Nakanishi; Satoshi Nimura; Masahiko Sato; Kazuaki Shimada; Katsutoshi Miura; Michiie Sakamoto
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

2.  A man with an enlarging foot mass.

Authors:  Ali Zahrai; Deloar Hossain; John M Embil; Elly Trepman
Journal:  CMAJ       Date:  2004-11-23       Impact factor: 8.262

3.  Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia Syndrome.

Authors:  Mary Scott Ramnitz; Pravitt Gourh; Raphaela Goldbach-Mansky; Felasfa Wodajo; Shoji Ichikawa; Michael J Econs; Kenneth E White; Alfredo Molinolo; Marcus Y Chen; Theo Heller; Jaydira Del Rivero; Patricia Seo-Mayer; Bita Arabshahi; Malaka B Jackson; Sarah Hatab; Edward McCarthy; Lori C Guthrie; Beth A Brillante; Rachel I Gafni; Michael T Collins
Journal:  J Bone Miner Res       Date:  2016-09-20       Impact factor: 6.741

4.  Clinical and genetic analysis of idiopathic normophosphatemic tumoral calcinosis in 19 patients.

Authors:  Q-Y Zuo; X Cao; B-Y Liu; D Yan; Z Xin; X-H Niu; C Li; W Deng; Z-Y Dong; J-K Yang
Journal:  J Endocrinol Invest       Date:  2019-09-18       Impact factor: 4.256

5.  Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis.

Authors:  Alan Yancovitch; Dov Hershkovitz; Margareta Indelman; Peter Galloway; Margo Whiteford; Eli Sprecher; Esra Kılıç
Journal:  J Bone Miner Metab       Date:  2011-02-25       Impact factor: 2.626

6.  Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family.

Authors:  M F Campagnoli; A Pucci; E Garelli; A Carando; C Defilippi; R Lala; G Ingrosso; I Dianzani; M Forni; U Ramenghi
Journal:  J Clin Pathol       Date:  2006-04       Impact factor: 3.411

Review 7.  Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature.

Authors:  M Chakhtoura; M S Ramnitz; N Khoury; G Nemer; N Shabb; A Abchee; A Berberi; M Hourani; M Collins; S Ichikawa; G El Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2018-06-20       Impact factor: 4.507

Review 8.  Review of tumoral calcinosis: A rare clinico-pathological entity.

Authors:  Ibrahim Fathi; Mahmoud Sakr
Journal:  World J Clin Cases       Date:  2014-09-16       Impact factor: 1.337

9.  Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification.

Authors:  Eli Sprecher
Journal:  J Invest Dermatol       Date:  2009-10-29       Impact factor: 8.551

10.  Osteoclast-like multi-nucleated giant cells in uraemic tumoral calcinosis.

Authors:  Shunsuke Yamada; Masatomo Taniguchi; Masanori Tokumoto; Kazuhiko Tsuruya; Mitsuo Iida
Journal:  NDT Plus       Date:  2009-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.